Unity Biotechnology (LTS:0YC0) Construction In Progress: $0.00 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0YC0 Unity Biotechnology Inc LTS:0YC0
25 GF Score
Price $0.06
View Full Analysis

What is Unity Biotechnology Construction In Progress?

Unity Biotechnology LTS:0YC0 25 Construction In Progress is $0.00 Mil as of Mar. 2025. GuruFocus rates LTS:0YC0 with a GF Score™ of 25/100.

Unity Biotechnology Construction In Progress Historical Data

* Premium members only.

The historical data trend for Unity Biotechnology's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unity Biotechnology Construction In Progress Chart

Unity Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 0.00 0.01 0.00 0.00 0.00

Unity Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0YC0
25GF Score
Unity Biotechnology Inc LTS:0YC0
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unity Biotechnology Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.00 Mil mean?
Unity Biotechnology (LTS:0YC0) has a Construction In Progress of $0.00 Mil as of Mar. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Unity Biotechnology and its competitors.
Is Unity Biotechnology's Construction In Progress too high?
Unity Biotechnology's current Construction In Progress is $0.00 Mil. Overall, Unity Biotechnology has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Unity Biotechnology's Construction In Progress compare to ADTX and HEPA?
Unity Biotechnology's Construction In Progress of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Unity Biotechnology and its competitors. Unity Biotechnology's current Construction In Progress is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unity Biotechnology stock overvalued right now?
Unity Biotechnology (LTS:0YC0) has a current Construction In Progress of $0.00 Mil. The current Construction In Progress is $0.00 Mil. Unity Biotechnology's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Unity Biotechnology (LTS:0YC0), the current Construction In Progress is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Unity Biotechnology Business Description

Address 285 East Grand Avenue, South San Francisco, CA, USA, 94080
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
25GF Score

Get the complete analysis for LTS:0YC0

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price